Screener
Xenon Pharmaceuticals XENE Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
FAQ
- What is Xenon Pharmaceuticals's total assets?
- Xenon Pharmaceuticals (XENE) reported total assets of $1.3B in Q2 2026.
- How has Xenon Pharmaceuticals's total assets changed year-over-year?
- Xenon Pharmaceuticals's total assets increased by 92.2% year-over-year, from $674.28M to $1.3B.
- What is the long-term trend for Xenon Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's total assets has grown at a 27.3% compound annual growth rate (CAGR), from $189.19M to $633.16M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Xenon Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude